Company Performance Metrics
- Matthew Tindall: CEO and FounderPast Role: Fabric Genomics (formerly Omicia), Chief Executive Officer
- Curtis Scribner: Co-Founder, Chief Medical Officer and Head of Clinical and Regulatory
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
The company is bridging scientific unknowns by interrogating disparate fields of biology, taking risks, innovating, and deploying potentially orthogonal approaches to achieve desired outcomes. It is working with leading scientists,
therapeutics, and diagnostics experts across multiple scientific disciplines within several esteemed academic institutions and government agencies to create novel, targeted solutions.
The company was founded in 2019 and is based in Berkeley, California.
